Study Hijacking: When “Science-Backed” Isn’t Backed By Your Product

Study Hijacking: When “Science-Backed” Isn’t Backed By Your Product

Just Because a Study Exists Doesn’t Mean Your Supplement Works

You’ve seen it: “Clinically proven to boost focus!” But did the study use the same ingredient? Same dose? Same delivery? Probably not. This is study hijacking — borrowing credibility from real science… while selling something completely different.


🔍 What Is Study Hijacking?

Citing a legitimate scientific study — but for a different form, dose, or delivery method than what’s in the product.

Example:

  • Study used 200mg Suntheanine® + caffeine → improved reaction time
  • Your supplement has 50mg generic L-Theanine → cites the same study

That’s not “backed by science.” That’s borrowing science.


🧪 How Companies Do It

  • Say: “PQQ shown to support mitochondria!”
    But use 5mg, not 20mg — and not BioPQQ®
  • Say: “Lion’s Mane supports memory!”
    But use mycelium on grain, not fruiting body
  • Say: “MCT oil boosts ketones!”
    But use slow C10/C12 oils, not fast C8

They let the science do the talking — while their product stays silent.


🚪 How They Get Away With It

  • Phrases like “studies show” or “research suggests” are vague
  • No legal requirement to match the study conditions
  • Consumers assume “if it’s in the study, it works”

🔴 Red Flag to Watch For

❗ If a brand cites a study but uses a different ingredient, lower dose, or cheaper form — the claim doesn’t apply.

Always ask:

  • Was it the same compound?
  • Same amount?
  • Same population?

If not — it’s hijacked science.


⚖️ Real Example: FTC Warning Letters (2022) to CBD Companies

The FTC issued warnings to multiple CBD brands for citing studies on pure, pharmaceutical-grade CBD — while selling low-potency, untested products with minimal CBD content. They were told to stop making unsupported claims.

✅ Outcome: Brands revised marketing materials and removed misleading citations.

Reading next

Dose Undercutting: When “Just Enough” Means “Not Enough”
Patent Avoidance: The Cheap Copy That Doesn’t Work

Leave a comment

All comments are moderated before being published.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.